We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
Join OCT Clinical at the BIO International Convention, the largest event in biotechnology, bringing together over 20,000 industry leaders worldwide.
At this global partnering event, uniting emerging biotech companies, health biotechnology industry, agriculture and environment, OCT Clinical will be represented by Anna Yanaeva, Head of Business Development. Contact Anna at ayanaeva@oct-clinicaltrials.com to book a meeting with us to discuss your clinical trial options in Eastern Europe.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.